Chemed Sees FY24 EPS $23.30-$23.70 Vs $23.52 Est.
Chemed Sees FY24 EPS $23.30-$23.70 Vs $23.52 Est.
Chemed預計24財年每股收益爲23.30美元至23.70美元，而美國東部標準爲23.52美元。
Guidance for 2024
2024 年指導方針
Management reiterates its estimated full-year 2024 earnings per diluted share, excluding: non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, and other discrete items, guidance range of $23.30 to $23.70. Management anticipates providing updated 2024 earnings guidance and related subsidiary operating metrics as part of the June 30, 2024 earnings press release.
管理層重申其預計的2024年全年攤薄後每股收益，其中不包括：股票期權的非現金支出、股票期權行使的稅收優惠、訴訟相關成本和其他離散項目，指導區間爲23.30美元至23.70美元。管理層預計，作爲2024年6月30日業績新聞稿的一部分，提供最新的2024年收益指導和相關的子公司經營指標。